Please Wait
Applying Filters...
menu
    • menu
    Top first-in-class drug candidates of 2025: Ionis’ donidalorsen, Sanofi’s fitusiran, Cytokinetics’ aficamten await FDA approval

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

    Stock Recap
    #PipelineProspector

    Menu

    Nexavar

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,355Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    30/12/2024 Bayer AG
    Germany
    		 Bayer Korea Ltd. Su2420-1-ND Sorafenib tosylate 2007-12-28 Bayer AG@Bayer AG Germany Friedrich-Ebert-Str.217-333, 42117,Wuppertal,Germany_x000D_ @51368 leverkusen
    30/12/2024 Cipla
    India
    		 UNUST Co., Ltd. No. 4838-16-ND Sorafenib tosylate 2012-07-13 Cipla Limited India Plot No. 285, 286 & 287 KIADB, IV PHASE, Jigani - Bommasandra Link Road, Bommasandra, Bangalore - 560 099